News – Page 336
-
ResearchPill endocrine disruptor cleaned up by catalyst
Cheap iron catalysts could cut cost of tackling synthetic oestrogen in wastewater in half
-
Business
Suspect suicide won’t end trade secret theft probe
An ex-PPG chemist who was arrested for selling trade secrets to a Chinese firm has killed himself, but the Justice Department will continue its investigation
-
ResearchDNA inspires smart phospholipids
Liposomes made from synthetic nucleoside phospholipids could benefit drug delivery
-
NewsChemical sciences literature dominated by five publishing houses
Big five control publishing of more than 50% of global academic papers, rising to over 70% in chemistry
-
News
US spends billions annually on unreproducible preclinical research
Study estimates $28 billion spent yearly on preclinical research that can’t be replicated
-
BusinessCompanies clamour for CAR-T
Engineered immune cell therapies show promise in early cancer trials, prompting firms to compete for a foothold in the field
-
NewsSecurity experts warn chemical plants are vulnerable to cyber-attacks
Action is needed to protect chemical plants and other infrastructure from hackers
-
ResearchX-rays capture super-fast nanoscale film
Chance finding underlines nanodiffraction technique’s power and potential
-
Business
Vertex nabs rights to cystic fibrosis molecules
Deal with Parion, worth up to $1bn, gives firm worldwide rights to investigational treatments that complement Vertex’s existing cystic fibrosis drugs
-
Business
Opko deepens diagnostics with $1.5bn lab buyout
Taking over clinical diagnostics service provider BioReference Laboratories gives Opko a bigger avenue to distribute and market its diagnostic tests
-
News
NIH drug manufacturing unit shut down
The US National Institutes of Health suspends operations at its pharmaceutical development section after FDA inspectors uncover serious manufacturing issues
-
NewsWarnings that proposed UK blanket ban on 'legal highs' casts net too wide
Experts concerned by vague definitions and effect on neuroscience research
-
ResearchInjectable electronics unfold to monitor brain activity
Electronics a million times more flexible than the best currently available could transform patient monitoring
-
BusinessBMS sues executive for joining rival company
Bristol-Myers Squibb’s lawsuit against its former immuno-oncology chief who left to work for AstraZeneca has implications for biopharma industry
-
ResearchMicrofluidic approach to personalised cancer treatment
Multiple myeloma drug response assay could be adapted for other cancers
-
Business
Takeda to consolidate vaccines business in Boston
Firm will close three recently-acquired US sites and shift operations to the growing pharmaceutical hub in Massachusetts
-
News
Call to embed science in US foreign policy
National Research Council tells US to take science and technology more seriously on the diplomatic stage
-
NewsBiosafety blunder as US sends live anthrax to labs around world
Key government committee demands answers after Department of Defense inadvertently sends out live pathogen
-
NewsChemistry Nobel laureate Irwin Rose dies aged 88
Biochemist revealed protein pathway for cell breakdown
-
NewsPostdocs struggle with poor job security and stress in Europe
Career study finds flexibility of temporary contracts delivers poor returns for both employer and employee